← Back to directory

Vincenzo Mazzaferro

Researcher Next ID · RN-030159

Researcher · Medicine

Tumori Foundation

San Francisco, Italy

Not currently recruitingFunding unknown
Works count
782
Citation count
90,406
H-index
110
i10-index
388

Research interests

Medicine
Hepatocellular Carcinoma Treatment and Prognosis
Organ Transplantation Techniques and Outcomes
Liver Disease Diagnosis and Treatment
Cholangiocarcinoma and Gallbladder Cancer Studies
Liver Disease and Transplantation

Publications

  • EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma

    Journal of Hepatology · 2024 · https://doi.org/10.1016/j.jhep.2024.08.028

  • Immunotherapies for hepatocellular carcinoma

    Nature Reviews Clinical Oncology · 2021 · https://doi.org/10.1038/s41571-021-00573-2

  • BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

    Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.11.018

  • Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference

    Transplantation · 2020 · https://doi.org/10.1097/tp.0000000000003174

  • Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial

    The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30224-2

  • First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma

    Cancer Discovery · 2019 · https://doi.org/10.1158/2159-8290.cd-19-0555

  • Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

    The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30146-3

  • EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

    Journal of Hepatology · 2018 · https://doi.org/10.1016/j.jhep.2018.03.019

  • Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features

    Gastroenterology · 2017 · https://doi.org/10.1053/j.gastro.2017.06.007

  • Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations

    Gut · 2017 · https://doi.org/10.1136/gutjnl-2017-314828

  • Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation

    Gastroenterology · 2016 · https://doi.org/10.1053/j.gastro.2016.11.042

  • Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment

    Hepatology · 2016 · https://doi.org/10.1002/hep.28744

  • The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors

    American Journal of Transplantation · 2016 · https://doi.org/10.1111/ajt.13831

  • Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma

    British journal of surgery · 2016 · https://doi.org/10.1002/bjs.10137

  • Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma

    Transplantation · 2015 · https://doi.org/10.1097/tp.0000000000000965

  • Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

    The Lancet Oncology · 2015 · 10.1016/s1470-2045(15)00198-9

  • Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

    Nature Genetics · 2015 · 10.1038/ng.3252

  • Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study

    Journal of Hepatology · 2013 · https://doi.org/10.1016/j.jhep.2013.02.026

  • EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

    Journal · 2012

  • Resection of hepatocellular cancer ≤2 cm: Results from two Western centers

    Hepatology · 2012 · https://doi.org/10.1002/hep.25832

  • Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

    Journal of Hepatology · 2012 · 10.1016/j.jhep.2012.06.014

  • Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience

    Liver Transplantation · 2011 · https://doi.org/10.1002/lt.22365

  • Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

    The Lancet Oncology · 2008 · 10.1016/s1470-2045(08)70284-5

  • Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

    New England Journal of Medicine · 2008 · 10.1056/nejmoa0804525

  • Sorafenib in Advanced Hepatocellular Carcinoma

    New England Journal of Medicine · 2008 · 10.1056/nejmoa0708857

  • Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis

    Hepatology · 2006 · https://doi.org/10.1002/hep.21415

  • Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation

    Annals of Surgery · 2004 · https://doi.org/10.1097/01.sla.0000143301.56154.95

  • Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer.

    PubMed · 2003

Current projects

    No projects listed.